ADSL and chronic lung disease: Findings reported that lysozyme, lactoferrin, secretory leukocyte proteinase inhibitor (SLPI), and LL-37 are prominent and abundant AMPs within the airway, exhibiting altered expression patterns in chronic lung diseases [19,20,21,22].